Your browser doesn't support javascript.
loading
Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study.
Javle, Milind; Borad, Mitesh J; Azad, Nilofer S; Kurzrock, Razelle; Abou-Alfa, Ghassan K; George, Ben; Hainsworth, John; Meric-Bernstam, Funda; Swanton, Charles; Sweeney, Christopher J; Friedman, Claire F; Bose, Ron; Spigel, David R; Wang, Yong; Levy, Jonathan; Schulze, Katja; Cuchelkar, Vaikunth; Patel, Arisha; Burris, Howard.
Afiliação
  • Javle M; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: mjavle@mdanderson.org.
  • Borad MJ; Mayo Clinic, Scottsdale, AZ, USA.
  • Azad NS; Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Kurzrock R; Moores Cancer Center, University of California San Diego, San Diego, CA, USA.
  • Abou-Alfa GK; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Medical College at Cornell University, New York, NY, USA.
  • George B; Medical College of Wisconsin, Milwaukee, WI, USA.
  • Hainsworth J; Sarah Cannon Research Institute, Nashville, TN, USA; Tennessee Oncology, Nashville, TN, USA.
  • Meric-Bernstam F; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Swanton C; Francis Crick Institute, London, UK; UCL Hospitals, London, UK.
  • Sweeney CJ; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Friedman CF; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Medical College at Cornell University, New York, NY, USA.
  • Bose R; Washington University School of Medicine, St Louis, MO, USA.
  • Spigel DR; Sarah Cannon Research Institute, Nashville, TN, USA; Tennessee Oncology, Nashville, TN, USA.
  • Wang Y; Genentech, South San Francisco, CA, USA.
  • Levy J; Genentech, South San Francisco, CA, USA.
  • Schulze K; Genentech, South San Francisco, CA, USA.
  • Cuchelkar V; Genentech, South San Francisco, CA, USA.
  • Patel A; Genentech, South San Francisco, CA, USA.
  • Burris H; Sarah Cannon Research Institute, Nashville, TN, USA; Tennessee Oncology, Nashville, TN, USA.
Lancet Oncol ; 22(9): 1290-1300, 2021 09.
Article em En | MEDLINE | ID: mdl-34339623
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Biliar / Receptor ErbB-2 / Anticorpos Monoclonais Humanizados / Trastuzumab / Antineoplásicos Imunológicos Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Biliar / Receptor ErbB-2 / Anticorpos Monoclonais Humanizados / Trastuzumab / Antineoplásicos Imunológicos Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de publicação: Reino Unido